Call(WhatsApp Us)
+8615360806100Email Us
cherry@laeyo.comSee the factory by live video walkthrough
Book an on-site factory visit in GuangzhouOcular tolerance evidence helps assess eye-area safety under the conditions studied; it does not guarantee that no user will experience irritation. A qualified safety assessor and the testing laboratory should determine the evidence needed…
Ocular tolerance evidence helps assess eye-area safety under the conditions studied; it does not guarantee that no user will experience irritation. A qualified safety assessor and the testing laboratory should determine the evidence needed for the formula, intended use, foreseeable exposure and claims.
Ocular tolerance assessment considers potential effects on the eye and surrounding tissues under intended use and foreseeable exposure. The endpoints and methods should be selected for the product rather than assuming that every study deliberately introduces product into the eye.
Methods differ in purpose and applicability. Ask a qualified safety assessor and laboratory which methods are suitable for the formula, exposure scenario, claims and target market.
The periorbital skin is four times thinner than the rest of the face, and the tear film can quickly dissolve water-soluble irritants, delivering them directly to the cornea. Regulatory bodies and retailers increasingly expect brands to substantiate “safe for use around eyes” or “ophthalmologist-tested” claims. Without clear evidence, you risk:
Not every product needs a full ophthalmologist-led study. Here’s how to decide based on your situation:
For products used on or near the eye, ask a qualified safety assessor to review intended placement and foreseeable exposure before selecting evidence or additional studies. A particular in vitro or human study is not a universal minimum for every eye-area product.
Changes in preservatives, surfactants, fragrance or raw material suppliers can affect the irritation profile. Have the responsible assessor review the change and document whether existing evidence remains applicable or additional work is needed.
Review the applicable safety-assessment and claim-substantiation requirements in each destination market with qualified regulatory support. Do not assume that one method or report is accepted for every product, claim and market.
Claims such as “no tears,” “eyelid-safe,” or “ophthalmologist tested” need evidence appropriate to their exact wording and intended use. A qualified assessor and laboratory should determine the study design and limitations; a “dermatologically tested” claim alone does not establish ocular tolerance.
Sprays, pump-activated liquids, and powders that can become airborne present a higher risk of accidental eye contact. Any product in these formats should be evaluated even if it isn’t marketed specifically as an eye product—because real-world use often leads to eye exposure.
The table lists study approaches to discuss with a qualified assessor and laboratory, not a universal testing sequence. Confirm suitability, review requirements, endpoints and project-specific timing before commissioning work.
| Study approach | Assessment question | Applicability review | Timing |
|---|---|---|---|
| In vitro methods | Potential irritation under the selected method | Confirm method applicability, limitations and relevance to the finished formula and market | Confirm with the laboratory |
| HET-CAM | Screening information where appropriate | Confirm suitability and limitations; do not assume it establishes a finished-product claim | Confirm with the laboratory |
| Human-use study | Tolerance under a defined use protocol | Requires an appropriately reviewed protocol and qualified clinical oversight; not a universal requirement | Protocol and recruitment dependent |
| Skin tolerance study | Skin responses under the study conditions | Assessor to determine relevance; does not replace ocular exposure assessment or guarantee no irritation | Protocol dependent |
When you work with a contract manufacturer or formulator, be explicit about your needs early. Use these talking points:
Evidence requirements depend on the product, intended use, claims and market. Have qualified regulatory support and the responsible safety assessor identify the applicable requirements and document why the chosen evidence is sufficient; do not assume one named test is mandatory for all eye cosmetics.
An in vitro result alone should not be treated as proof of every consumer-use claim. Ask a qualified assessor and laboratory what evidence supports the exact claim. Any human-use study must have appropriate protocol review and professional supervision.
Powders may present foreseeable eye exposure and mechanical irritation concerns. The assessor should consider the formula, particle characteristics, intended use and microbiological risks and determine the evidence needed; do not prescribe a fixed test combination for every powder.
Existing data from a similar base may be relevant, but similarity alone does not establish safety. Ask the responsible assessor to document the differences, applicability and limitations of read-across and whether additional evidence is needed.
Review whether existing evidence still applies when the formula, raw materials, packaging, intended use, claims or relevant requirements change. The responsible safety assessor should document whether existing data remain sufficient or additional work is needed.
Eye-area products require extra care, but the investment in the right testing pays off in consumer trust and market access. To discuss your product’s specific needs and get a custom quote, Request a Quote from our team today.